Introduction
In vitro degradation of b 2 -M amyloid deposits 1193 done at 25°C for 2 h shaking gently. The enzymatic reactions
Based on Skogen and Natvig's work [21] , we wanted were stopped with ethylene diamine tetracetic acid ( EDTA) to extend the study of in vitro degradation of amyloid 0.2 M. After protease incubation, the supernatants and pellets fibrils to b 2 M amyloidosis. Our aim was to assess in were separately used for protein analysis. Controls were done vitro the ability of diÂerent proteases to degrade DRA with the omission of proteases in PBS, both with and without deposits and amyloid fibrils. We sought to identify the a 2 M. The experiments of protease incubations were repeated proteins removed from the amyloid deposits by diÂer-twice with diÂerent aliquots of the amyloid deposits from ent proteases in order to establish a hypothetical the three patients. solubility gradient. This should provide information on the stability of the attachment for a given protein Protein preparation which influences the non-degradation of the amyloid deposits. Finally, we wanted to test the influence of Proteins were extracted by precipitation with trichloroacetic a 2 M on the protease-induced resorption of proteins acid ( TCA) as previously described [24] . Briefly, the amyloid from the amyloid deposits.
deposits and the fibril preparations after protease incubations were crushed under liquid nitrogen at −80°C. A 10% TCA solution was added to precipitate proteins. Ethanol-ether
Subjects and Methods
solutions with an increasing ether concentration (90, 95 and 100%), were used after thawing to eliminate TCA and lipid constituents. Washes and centrifugations were done twice for
Patients and sample preparation each ethanol-ether solution. Supernatants were discarded and pellets dried under nitrogen and stored at −70°C until Three patients maintained on haemodialysis for more than protein analysis. 15 years were included in the study; they had undergone surgery for a carpal-tunnel syndrome. The surgery obtained the relief of symptoms and the material removed was amyloid Sodium dodecylsulphate polyacrylamide gel of b 2 -microglobulin type. The clinical characteristics of the electrophoresis (SDS-PAGE)
patients are depicted in Table 1 . b 2 -Microglobulin fibrils were obtained from the amyloid TCA precipitated pellets and supernatants were solubilized deposits surgically obtained, following a modification of in 6 M urea, 5 mM dithiothreitol (DTT ), 1% SDS and Gorevic et al's method [23 ] . Briefly, after three freeze-thaw 50 mM Tris-HCl, pH 6.8 and centrifuged at 10 000 r.p.m. cycles the deposits were homogenized with a Polytron for 2 min. The supernatants were withdrawn for 5-20% (w/v) ( Kinematica, GmbH, Luzern, Switzerland) in 0.1 SDS-PAGE performed using a discontinuous buÂer system M phosphate-buÂered saline (PBS) and centrifugated at as described by Laemmli [25 ] . The molecular weight markers 13 000 r.p.m. for 30 min at 4°C in a Sorvall RC-5B centrifuge. used were a-lactalbumin (14.4 kDa), soybean trypsin inhibThis step was repeated discarding the supernatant until it itor (20.1 kDa), carbonic anhydrase (30 kDa), ovalbumin was free of protein (Bradford assay, Bio-Rad reagents). The (43 kDa), bovine serum albumin (67 kDa), and phosphorylpellets were enriched in amyloid fibrils. Each amyloid deposit ase b ( 94 kDa). Gels were stained with Coomassie blue. was studied separately.
Western blotting Protease incubations
Protein transfer from polyacrylamide to nitrocellulose sheets Protease incubations were performed based on the work by (0.45 mm) was performed according to Burnette et al's Skogen and Natvig [21] with some modifications. Trypsin method [26 ] . Polyclonal antibodies against b 2 M, a 2 M, l and collagenase proteases were purchased from Boehringer and k light chains of immunoglobulin were purchased ( Mannheim, Germany) and kallikrein was purchased from from Nordic Immunological Laboratories ( Tilburg, The Sigma (St Louis, USA). The proteases were dissolved in PBS Netherlands). The second antibodies were goat anti-0.1 M, pH 7.4 at a concentration of 10 mg/ml immediately rabbit and rabbit anti-goat immunoglobulin G conjugated before use. Both, amyloid deposit fragments and amyloid with horseradish peroxidase (Nordic Immunological fibril preparations were incubated separately with each pro-Laboratories). Horseradish peroxidase was visualized with tease and also treated with the three proteases together. We an enhanced chemiluminescence detection kit ( Amersham did the same experiments in the presence of a 2 macroglobulin CEA, AB, Sweden) and exposed to Hyperfilm ECL (Sigma, St Louis, USA) at 2.7 10−7 M. The incubations were (Amersham). submitted to the respective treatments, by electron microscopy and gold immunolabelling. embedded in Lowicryl K4M (Chemische Werke Lowi, WaldKraiburg, Germany). Ultrathin sections (40-60 nm) were mounted on formvar coated and etched gold grids.
Gold immunolabelling
The immunogold protocol included the following incubation and wash steps, which were performed in phosphate-buÂered saline (PBS ) at room temperature in a wet chamber: ( 1) two blocking rinses in 100 mM glycine-PBS, ( 2) 30 min incubation with 2% ovalbumin to block non-specific binding, (3 ) 2 h incubation with a polyclonal anti-human b 2 -microglobulin antibody (Dakopatts, Glostrup, Denmark) diluted 15500 in shows the proteins contained in the supernatants obtained from together ( lane 4 ). Lane 5 was the control sample, using PBS alone. The experiments were repeated in ( A) the absence and ( B) the amyloid deposits, and panel (B) shows the proteins contained in the supernatants obtained from the prepurified amyloid fibrils. presence of a 2 M in the medium.
In vitro degradation of b 2 -M amyloid deposits 1195 globulin was almost exclusively located within amyloid fibrils. Very seldom were gold particles observed distant from amyloid fibrils. The amyloid deposits treated with trypsin displayed a decrease in the non-amyloid matrix when compared to the PBS treated samples. However, the counts of labelled b 2 M did not diÂer when comparing PBS and trypsin treated samples (respectively 250±20 and 242±31 gold particles/mm2, NS). An example of these preparations is given in Figure 6 -A and 6-B.
The morphological analysis of amyloid fibrils showed a decrease in the non-amyloid matrix in both samples, PBS and trypsin treated, when compared to the amyloid deposits without prepurification. However, antibody. Prepurified amyloid fibrils were incubated with the same the trypsin treatment in prepurified amyloid fibrils did proteases as those shown in previous Figures ( lanes 1-5) . The not enhance the removal of non-amyloid matrix when experiments were performed in ( A) the absence and (B) the presence compared to the PBS-treated samples. The density of a 2 M.
of gold particles was similar in both PBS and trypsin-treated conditions and they were not signifipositive band at 12 kDa mol wt and a second one at cantly diÂerent from the unprepared amyloid deposits 24 kDa mol wt, suggesting that dimers of b 2 M can be (respectively 232±21 and 227±12 gold particles/mm2, extracted from the amyloid fibrils in addition to mon-NS) ( teins present in the amyloid deposits, such as a 2 M again suggesting that the proteins contained in amyloid [28] , light chains of immunoglobulins [24,29], deposits, and particularly b 2 M, can be released only amyloid P substance [23, 30] , and glucosaminoglycans by the action of ionic forces, even in prepurified [31, 32] . From the clinical side, a lack of correlation amyloid fibrils. It is to be stressed that b 2 M could also between serum levels of b 2 M and the prevalence of be solubilized in these experiments.
DRA was reported very early [4 ] . Further, we have recently reported that the modifications in b 2 M, which Morphological studies were previously proposed as specific for amyloidosis, Electron-microscopy and immunolabelling with anti-can be found in other non-amyloid situations [8, 33] . b 2 -microglobulin antibodies, showed that b 2 -micro-Taken together, these data suggest that the reasons for amyloid deposit formation cannot be found only in the changes in serum levels of b 2 M nor in the known alterations of the protein itself.
Since a participation of the other protein components of b 2 M amyloid deposits cannot be ruled out at present, we wanted to study their possible role. We decided to study the ability of recovering the diÂerent proteins from the amyloid deposits. By doing these experiments, we aimed to establish a sort of solubilization gradient and to evaluate the diÂerential strength of linkage between each protein and the amyloid deposit.
Skogen and Natvig used a similar approach in their study of human secondary amyloidosis [21 ]. They M amyloidosis, as previously tion [37] . These observations suggest that the factors responsible for the undegradability of amyloid proteins reported [18, 34] . Second, and more importantly, it shows that these proteins can be extracted from the do not exist anymore when guanidine solubilization and liophylization are preferred to TCA precipitation amyloid deposits in vitro. Further, and to our surprise, the proteins were recovered in the supernatants of the in preparing amyloid fibrils. Whether these factors are conformational or some amyloid constituents retained amyloid deposits and prepared fibrils, incubated with PBS alone, showing that there is no need for proteases only with TCA precipitation has not been elucidated by our studies. to break their attachment with the amyloid deposits. Our morphology studies showed that the modifications The present data again stress the importance of the technical approach used in studying amyloid deposits, induced by trypsin treatment on crude amyloid deposits were very similar to those observed with the accepted as we have previously reported [38] . After the final homogenization step of the amyloid deposits with PBS, method for amyloid fibril preparation. Namely, there was a decrease in the extracellular matrix-like struc-the absence of protein in the supernatants was confirmed by the very sensitive Bradford assay; however, tures of the amyloid deposits onto which the amyloid fibrils are observed. Interestingly, the morphology stud-after 2-and 3-h incubation with PBS, the supernatants contained again significant amounts of proteins, and ies of amyloid fibrils showed that trypsin did not enhance the purity of the preparation, and it was importantly, these proteins were not merely contaminants. They included b 2 M and light chains of immunounable to extract more b 2 M from the pellets of amyloid fibrils, suggesting that the solubilization of the amyloid globulins which have both been located within the amyloid fibrils by ultrastructural immunogold labelproteins depends on ionic forces, rather than on a proteolytic activity provided by the protease added. ling. Therefore the incubation time is likely to be an important factor in resuspending the proteins conThus, the amyloid proteins in the amyloid deposits would be resistant to proteases, either because of their tained in the prepurified amyloid fibrils with PBS in vitro. Although in a diÂerent situation from that of unique space conformation, because of the presence of antiproteases or because of the participation of other amyloid deposits, Clark et al. [39 ] were able to recover b 2 -microglobulin adsorbed in dialysis membranes by unknown factors [28, 35] . We have recently reported that resuspended amyloid fibrils obtained following a using PBS alone when measuring the adsorptive capacities of b 2 -microglobulin for diÂerent dialysis memmodification of Pras et al.'s [36 ] method, are degradable in vitro by the action of trypsin, and that a 2 M branes [39 ] .
Another new finding of the present work, was the protects some of the amyloid proteins from degrada-after renal transplantation. 
